
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
Liu Guang-na, Motao Zhu, Xiao Zhao, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113889-113889
Closed Access | Times Cited: 78
Liu Guang-na, Motao Zhu, Xiao Zhao, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113889-113889
Closed Access | Times Cited: 78
Showing 1-25 of 78 citing articles:
Engineered Bacterial Outer Membrane Vesicles as Controllable Two‐Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor Immunotherapy
Qingqing Feng, Xiaotu Ma, Keman Cheng, et al.
Advanced Materials (2022) Vol. 34, Iss. 40
Closed Access | Times Cited: 116
Qingqing Feng, Xiaotu Ma, Keman Cheng, et al.
Advanced Materials (2022) Vol. 34, Iss. 40
Closed Access | Times Cited: 116
Nanocarriers based on bacterial membrane materials for cancer vaccine delivery
Xiao Zhao, Ruifang Zhao, Guangjun Nie
Nature Protocols (2022) Vol. 17, Iss. 10, pp. 2240-2274
Open Access | Times Cited: 110
Xiao Zhao, Ruifang Zhao, Guangjun Nie
Nature Protocols (2022) Vol. 17, Iss. 10, pp. 2240-2274
Open Access | Times Cited: 110
Biomimetic and bioinspired nano‐platforms for cancer vaccine development
Chenchao Feng, Peng Tan, Guangjun Nie, et al.
Exploration (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 78
Chenchao Feng, Peng Tan, Guangjun Nie, et al.
Exploration (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 78
Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity
Guangna Liu, Nana Ma, Keman Cheng, et al.
Nature Nanotechnology (2023) Vol. 19, Iss. 3, pp. 387-398
Closed Access | Times Cited: 61
Guangna Liu, Nana Ma, Keman Cheng, et al.
Nature Nanotechnology (2023) Vol. 19, Iss. 3, pp. 387-398
Closed Access | Times Cited: 61
Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy
Mingqi Liu, Yang Feng, Yougong Lu, et al.
Science Advances (2024) Vol. 10, Iss. 11
Open Access | Times Cited: 30
Mingqi Liu, Yang Feng, Yougong Lu, et al.
Science Advances (2024) Vol. 10, Iss. 11
Open Access | Times Cited: 30
Antithrombotic Therapy by Regulating the ROS‐Mediated Thrombosis Microenvironment and Specific Nonpharmaceutical Thrombolysis Using Prussian Blue Nanodroplets
Wenli Zhang, Junrui Wang, Zhuoyan Xie, et al.
Small (2022) Vol. 18, Iss. 15
Closed Access | Times Cited: 55
Wenli Zhang, Junrui Wang, Zhuoyan Xie, et al.
Small (2022) Vol. 18, Iss. 15
Closed Access | Times Cited: 55
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
Ziqi Wang, Kai Cui, Ulrich Costabel, et al.
Exploration (2022) Vol. 2, Iss. 5
Open Access | Times Cited: 44
Ziqi Wang, Kai Cui, Ulrich Costabel, et al.
Exploration (2022) Vol. 2, Iss. 5
Open Access | Times Cited: 44
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 33
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 33
Orchestrated Cytosolic Delivery of Antigen and Adjuvant by Manganese Ion-Coordinated Nanovaccine for Enhanced Cancer Immunotherapy
Zhen-Lin Gao, Wei Xu, Sui-Juan Zheng, et al.
Nano Letters (2023) Vol. 23, Iss. 5, pp. 1904-1913
Closed Access | Times Cited: 32
Zhen-Lin Gao, Wei Xu, Sui-Juan Zheng, et al.
Nano Letters (2023) Vol. 23, Iss. 5, pp. 1904-1913
Closed Access | Times Cited: 32
Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies
Yingying Hou, Min Chen, Yuan Bian, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3321-3338
Open Access | Times Cited: 29
Yingying Hou, Min Chen, Yuan Bian, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3321-3338
Open Access | Times Cited: 29
Long-acting vaccine delivery systems
Pavan Walvekar, Pradeep Kumar, Yahya E. Choonara
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114897-114897
Closed Access | Times Cited: 22
Pavan Walvekar, Pradeep Kumar, Yahya E. Choonara
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114897-114897
Closed Access | Times Cited: 22
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 12
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 12
Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
Ting Cai, Huina Liu, Shun Zhang, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 53
Ting Cai, Huina Liu, Shun Zhang, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 53
Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation
Andreea Crintea, A Duţu, Alina Simona Șovrea, et al.
Nanomaterials (2022) Vol. 12, Iss. 8, pp. 1376-1376
Open Access | Times Cited: 30
Andreea Crintea, A Duţu, Alina Simona Șovrea, et al.
Nanomaterials (2022) Vol. 12, Iss. 8, pp. 1376-1376
Open Access | Times Cited: 30
Metal-polyphenol “prison” attenuated bacterial outer membrane vesicle for chemodynamics promoted in situ tumor vaccines
Weidong Nie, Anqi Jiang, Ou Xu, et al.
Biomaterials (2023) Vol. 304, pp. 122396-122396
Closed Access | Times Cited: 21
Weidong Nie, Anqi Jiang, Ou Xu, et al.
Biomaterials (2023) Vol. 304, pp. 122396-122396
Closed Access | Times Cited: 21
Carbon Dots and Tumor Antigen Conjugates as Nanovaccines for Elevated Cancer Immunotherapy
Hongxin Liu, Zhigang Xie, Min Zheng
Small (2023) Vol. 19, Iss. 31
Closed Access | Times Cited: 20
Hongxin Liu, Zhigang Xie, Min Zheng
Small (2023) Vol. 19, Iss. 31
Closed Access | Times Cited: 20
Transforming Cold Tumors into Hot Ones with a Metal–Organic Framework-Based Biomimetic Nanosystem for Enhanced Immunotherapy
Manman Xu, Yincheng Chang, Guanghui Zhu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 14, pp. 17470-17484
Closed Access | Times Cited: 18
Manman Xu, Yincheng Chang, Guanghui Zhu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 14, pp. 17470-17484
Closed Access | Times Cited: 18
An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses
Ryotaro Oyama, Harumichi Ishigame, Hiroki Tanaka, et al.
ACS Nano (2023) Vol. 17, Iss. 19, pp. 18758-18774
Open Access | Times Cited: 18
Ryotaro Oyama, Harumichi Ishigame, Hiroki Tanaka, et al.
ACS Nano (2023) Vol. 17, Iss. 19, pp. 18758-18774
Open Access | Times Cited: 18
RNA Origami Functions as a Self-Adjuvanted Nanovaccine Platform for Cancer Immunotherapy
Theresa Yip, Xiaodong Qi, Hao Yan, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4056-4067
Closed Access | Times Cited: 7
Theresa Yip, Xiaodong Qi, Hao Yan, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4056-4067
Closed Access | Times Cited: 7
Self-adjuvanting polymeric nanovaccines enhance IFN production and cytotoxic T cell response
Ming Zhao, Chun‐Ting He, Xueyun Zheng, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 556-572
Closed Access | Times Cited: 7
Ming Zhao, Chun‐Ting He, Xueyun Zheng, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 556-572
Closed Access | Times Cited: 7
Boosting humoral and cellular immunity with enhanced STING activation by hierarchical mesoporous metal-organic framework adjuvants
Chengjie Huang, Xiao Zhi, Tianbao Ye, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 691-706
Closed Access | Times Cited: 7
Chengjie Huang, Xiao Zhi, Tianbao Ye, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 691-706
Closed Access | Times Cited: 7
Bacterial outer membrane vesicle-based cancer nanovaccines
Xiaoyu Gao, Qingqing Feng, Jing Wang, et al.
Cancer Biology and Medicine (2022) Vol. 19, Iss. 1, pp. 1290-1300
Open Access | Times Cited: 27
Xiaoyu Gao, Qingqing Feng, Jing Wang, et al.
Cancer Biology and Medicine (2022) Vol. 19, Iss. 1, pp. 1290-1300
Open Access | Times Cited: 27
Nanocarriers for effective delivery: modulation of innate immunity for the management of infections and the associated complications
Chung‐Nga Ko, Shaohong Zang, Yingtang Zhou, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 24
Chung‐Nga Ko, Shaohong Zang, Yingtang Zhou, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 24
Nanoparticles and Antiviral Vaccines
Sen L, Meilin Hu, Xiaoqing Liu, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 30-30
Open Access | Times Cited: 13
Sen L, Meilin Hu, Xiaoqing Liu, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 30-30
Open Access | Times Cited: 13
Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment
Liusheng Wu, Lei Yang, Xinye Qian, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 229-229
Open Access | Times Cited: 5
Liusheng Wu, Lei Yang, Xinye Qian, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 229-229
Open Access | Times Cited: 5